OpenAI Acquires Biomedical Company Orchestra Bio - AI

7 x 24 Track global technological trends

Hot Topic

Day

News Topic

OpenAI Acquires Biomedical Company Orchestra Bio

22 hour ago / Read about 0 minute

Author：小编

On October 21, 2026, OpenAI announced the acquisition of the biomedical research and development platform Orchestra Bio, integrating its technology into the Rosalind platform to accelerate new drug development.

Previous page：Foreign Ministry Responds to U.S. Demand for Feder...

Next page：Musk Reveals SpaceX and Tesla Have Set Up a Commit...

Return to List

Hot Reading

2 day ago

Samsung Outsources Nvidia AI Memory Base Dies to TSMC as Foundry Yields Fall Short

2 day ago

SK Hynix Debuts CXL Computational Memory on XCENA MX1; Samsung Commits as Foundry

2 day ago

MAI-Base-2 Pretraining Complete: Four Innovations Behind Microsoft's 4–12× Efficiency Claim

1 day ago

NVIDIA, Siemens Prove Autonomous Factory AI Needs No Prototypes; Erlangen Engineering Down 85%

1 day ago

Japan Clears TSMC Kumamoto for 3nm Chip Production; EUV Scarcity Caps Output at 6,000 Wafers

2 day ago

China's New AI Export Controls Apply Now if You Licensed or Deployed Covered Chinese Models

2 day ago

Tencent Hy-Memory Claims Open-Source Benchmark Lead Over Claude Opus 5 on Own Benchmarks

2 day ago

Sony hits PS6 snag – storage and memory alone could cost more than $680, so expect an eye-watering price tag

2 day ago

Apple's iPhone Duo cases present a sticky dilema – literally

1 day ago

Nvidia Denied RTX 5090 Discontinuation: Micro Center Still Says Not Carried

Previous page：Foreign Ministry Responds to U.S. Demand for Feder...

Next page：Musk Reveals SpaceX and Tesla Have Set Up a Commit...

C114 Communication Network
Communication Home

7 X 24 Track global technological trends

Find

News Topic

Hot Topic

7 x 24 Track global technological trends

News Flash

News Topic

AI
/
Devices
/
Smart Car
/
Chip
/
Cloud

C114 Communication Network

Communication Home